|
Volumn 96, Issue 5, 1994, Pages 451-456
|
Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use
a a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ARTICLE;
BONE MALFORMATION;
CONGENITAL MALFORMATION;
DRUG USE;
HUMAN;
HYPOTENSION;
INTRAUTERINE GROWTH RETARDATION;
KIDNEY FAILURE;
MORBIDITY;
MORTALITY;
NEWBORN DEATH;
OLIGOHYDRAMNIOS;
PATENT DUCTUS ARTERIOSUS;
PREGNANCY COMPLICATION;
PREMATURE LABOR;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
RESPIRATORY DISTRESS SYNDROME;
TERATOGENICITY;
|
EID: 0028276630
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/0002-9343(94)90172-4 Document Type: Review |
Times cited : (222)
|
References (39)
|